Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Denmark Clear all

463 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20018
20026
20037
20047
200513
200623
200713
200822
200925
201022
201123
201223
201325
201416
201526
201621
201719
201814
201914
202013
202121
202220
202318
202422
202510
202622

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed345
Unknown status47
Recruiting29
Active, not recruiting15
Terminated15
Not yet recruiting6
Enrolling by invitation4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S57
University of Aarhus53
Rigshospitalet, Denmark29
University Hospital, Gentofte, Copenhagen29
Steno Diabetes Center Copenhagen27
Odense University Hospital21
University of Copenhagen21
AstraZeneca16
Sanofi14
Boehringer Ingelheim13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2463
Diabetes Mellitus92
Obesity53
Insulin Resistance43
Diabetes Mellitus, Type 129
Cardiovascular Diseases26
Overweight18
Renal Insufficiency, Chronic18
Hypertension13
Metabolic Syndrome13

Trials

Showing 26 to 50 of 463. Each trial links to its page on Pharma Observatory.

363 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.